NCT07092384View on ClinicalTrials.gov

Effect of Remifentanil on Pruritus and Paresthesia of Fospropofol Disodium Anesthesia

NARecruitingINTERVENTIONAL
Enrollment

265

Participants

Timeline

Start Date

July 30, 2025

Primary Completion Date

November 30, 2025

Study Completion Date

December 31, 2025

Conditions
RemifentanilAdverse Effects
Interventions
DRUG

Remifentanil

Observe the incidence of pruritus and paresthesia after different doses of remifentanil and fospropofol disodium

DRUG

Sufentanil

Observe the incidence of pruritus and paresthesia after sufentanil and fospropofol disodium

Trial Locations (1)

430030

RECRUITING

Tongji Hospital, Wuhan

All Listed Sponsors
lead

Tongji Hospital

OTHER

NCT07092384 - Effect of Remifentanil on Pruritus and Paresthesia of Fospropofol Disodium Anesthesia | Biotech Hunter | Biotech Hunter